Cell Cycle Dysregulation Influences Survival in High Risk Breast Cancer Patients
Robert Königsberg(Kaiser-Franz-Josef-Spital), Christian Dittrich(Leibniz Institute for Agricultural Engineering and Bioeconomy), Marcus Hudec(University of Vienna), Maria De Santis(Medical University of Vienna), Walter Jäger, Olga Rögelsperger(Medical University of Vienna), Theresia Thalhammer(Medical University of Vienna), M. Klimpfinger(Kaiser-Franz-Josef-Spital)
Cited by 20
Related Papers
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
|European Urology|2016|1.5k
Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2020|786
European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part I
|European Urology|2008|617